132
Participants
Start Date
October 25, 2023
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
AT-1501
AT-1501 20 mg/kg administered every 3 weeks IV + MMF 1000 mg PO twice daily (BID) or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO once daily (QD) or equivalent
Tacrolimus
Tacrolimus dosed PO BID with the dose titrated to maintain a trough concentration of 6-8 ng/mL+ MMF 1000 mg PO BID or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO QD or equivalent
Royal Adelaide Hospital, Adelaide
Fiona Stanley Hospital, Perth
University of Pittsburgh Medical Center, Harrisburg
MedStar Georgetown University Hospital, Washington D.C.
John Hopkins University, Baltimore
Virginia Commonwealth University, Richmond
Duke University Medical Center, Durham
Emory University Hospital, Atlanta
Augusta University, Augusta
CHU de Toulouse - Hopital de Rangueil, Toulouse
Tampa General Hospital, Tampa
CHU Grenoble-Alpes - Hopital Nord Michallon, Grenoble
University of Cincinnati Medical Center, Cincinnati
Henry Ford Health System, Detroit
University of Minnesota Medical Center, Minneapolis
Mayo Clinic, Rochester
Loyola University Medical Center, Maywood
Washington University in St. Louis, St Louis
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
UT Southwestern, Dallas
University of California Los Angeles, Los Angeles
Keck School of Medicine of USC, Los Angeles
University of California, Davis Medical Center, Sacramento
Fundação Oswaldo Ramos - Hospital do Rim, São Paulo
Hospital das Clínicas da Faculdade de Medicina de São Paulo, São Paulo
St. Paul's Hospital, Vancouver
McGill University Health Care Centre, Montreal
Groupe Hospitalier Pellegrin, Bordeaux
Charite Universitatsmedizin Berlin, Berlin
Centre Hospitalier Universitaire Dupuytren, Limoges
Hospital del Mar - Parc de Salut Mar, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinical de Barcelona, Barcelona
Hospital Universitari de Bellvitge, Barcelona
Hospital Germans Trias i Pujol, Barcelona
Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital, Oxford
Lead Sponsor
Eledon Pharmaceuticals
INDUSTRY